A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis
Daniela María Cirillo, Richard Anthony, Sébastien Gagneux, C. Robert Horsburgh, Rumina Hasan, Saffiatou Darboe, Rafael Laniado-Laborin, Ari Probandari, et al. (28 authors)
The Lancet Global Health · 2024-07
Abstract
In September, world leaders will meet at the UN High-Level Meeting (UNHLM) on Antimicrobial Resistance (AMR).1 Drug-resistant tuberculosis is one of the major drivers of AMR-associated morbidity and mortality globally.2 The emergence and spread of AMR has set the tuberculosis response back decades. Advancement in research and political leadership, including through two UNHLMs on tuberculosis, have developed new pathways for progress in addressing tuberculosis.3 These efforts will be fatally undermined if governments fail to increase efforts to address AMR.
MeSH terms
- Tuberculosis
- High resistance
- Medicine
- Mycobacterium tuberculosis
- Antibiotic resistance
- Environmental health